Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Unlocking the Power of Plant-Derived Natural Products: Therapeutic Benefits for Cognitive Health and Neuropsychiatric Symptoms in Dementia-Related Diseases.
Journal: Plants (Basel, Switzerland)
Published: April 09, 2026
Manufacturing plant-made monoclonal antibodies for research or therapeutic applications.
Journal: Methods in enzymology
Published: November 07, 2021
Modulation of NKG2D, KIR2DL and Cytokine Production by Pleurotus ostreatus Glucan Enhances Natural Killer Cell Cytotoxicity Toward Cancer Cells.
Journal: Frontiers in cell and developmental biology
Published: April 14, 2019
Beta-caryophyllene enhances wound healing through multiple routes.
Journal: PloS one
Published: April 12, 2019
Development of the plant-derived peptide lunasin as an anticancer agent.
Journal: Current opinion in pharmacology
Published: February 11, 2018
Validation of syngeneic mouse models of melanoma and non-small cell lung cancer for investigating the anticancer effects of the soy-derived peptide Lunasin.
Journal: F1000Research
Published: February 16, 2017
The soy-derived peptide Lunasin inhibits invasive potential of melanoma initiating cells.
Journal: Oncotarget
Published: December 14, 2016
Lunasin is a novel therapeutic agent for targeting melanoma cancer stem cells.
Journal: Oncotarget
Published: May 16, 2016
The potential of plants as a system for the development and production of human biologics.
Journal: F1000Research
Published: May 12, 2016
The soybean-derived peptide lunasin inhibits non-small cell lung cancer cell proliferation by suppressing phosphorylation of the retinoblastoma protein.
Journal: Oncotarget
Published: November 25, 2014
Lunasin sensitivity in non-small cell lung cancer cells is linked to suppression of integrin signaling and changes in histone acetylation.
Journal: International journal of molecular sciences
Published: September 29, 2014
Last Updated: 09/26/2026